National Network Genomic Medicine Lung Cancer, Germany
NCT05934032 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30000
Last updated 2023-07-06
Summary
Registry of the national Network Genomic Medicine Lung Cancer (nNGM), linking data on molecular diagnostics, clinical characteristics, treatment patterns and outcomes of subjects with non-small cell lung cancer (NSCLC) from 23 specialized cancer centres and more than 400 general hospitals and oncological practices in Germany
Conditions
- Carcinoma, Non-Small-Cell Lung
Interventions
- OTHER
-
observational, non-interventional
observational, non-interventional
Sponsors & Collaborators
-
Charite University, Berlin, Germany
collaborator OTHER -
Helios Klinikum Emil von Behring
collaborator UNKNOWN -
Vivantes Hospital Berlin Neukölln
collaborator UNKNOWN -
University Hospital Carl Gustav Carus
collaborator OTHER -
Heinrich-Heine University, Duesseldorf
collaborator OTHER -
University Hospital Erlangen
collaborator OTHER -
University Hospital, Essen
collaborator OTHER -
Goethe University
collaborator OTHER -
University Hospital Freiburg
collaborator OTHER -
University Hospital Giessen and Marburg
collaborator UNKNOWN -
University Hospital Halle (Saale)
collaborator UNKNOWN -
Universitätsklinikum Hamburg-Eppendorf
collaborator OTHER -
University Hospital Heidelberg
collaborator OTHER -
Klinikum Hanover-Siloah Hospital
collaborator OTHER -
University Hospital, Bonn
collaborator OTHER -
University Hospital Schleswig-Holstein
collaborator OTHER -
Johannes Gutenberg University Mainz
collaborator OTHER -
University Hospital Munich (LMU)
collaborator UNKNOWN -
University Hospital rechts der Isar Munich (TUM)
collaborator UNKNOWN -
Pius-Hospital Oldenburg
collaborator OTHER -
University Hospital Regensburg
collaborator OTHER -
University Hospital Tuebingen
collaborator OTHER -
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
collaborator OTHER -
University Hospital Ulm
collaborator OTHER -
Wuerzburg University Hospital
collaborator OTHER -
University Hospital of Cologne
collaborator OTHER -
Prof. Dr. Juergen Wolf
lead OTHER
Principal Investigators
-
Juergen Wolf, Prof. Dr. · University of Cologne
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-01
- Primary Completion
- 2030-12-31
- Completion
- 2030-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Clinical and Molecular Study With Digital Support of Patients With Inoperable Lung Cancer
NCT05372081 ·Status: UNKNOWN
-
Lung Cancer Registry for Lung Cancer Patients
NCT03276429 ·Status: COMPLETED
-
Prospective Evaluation of Immunological, Molecular-genetic, Image-based and Microbial Analyzes to Characterize Tumor Response and Control in Patients With Inoperable Stage III NSCLC Treated With Chemoradiotherapy Followed by Consolidation Therapy With Durvalumab
NCT05027165 ·Status: UNKNOWN
-
Immune-Marker Platform for Patients With Advanced Lung Cancer
NCT07150598 ·Status: NOT_YET_RECRUITING
-
Prospective Clinicogenomic Program
NCT04180176 ·Status: COMPLETED ·Phase: PHASE4
-
Comprehensive Geriatric Assessment and Complications Following Lung Resection for Lung Cancer
NCT01956331 ·Status: COMPLETED
-
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
NCT01580982 ·Status: RECRUITING
-
DIAGNOSIS, TREATMENT AND OUTCOME OF LUNG CANCER PATIENTS
NCT05254119 ·Status: ACTIVE_NOT_RECRUITING
-
Next-generation Sequencing of Small Cell Lung Cancer to Identify Susceptibility Gene and to Assess Treatment
NCT03244904 ·Status: UNKNOWN
-
Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients.
NCT03220230 ·Status: COMPLETED
-
The Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCC
NCT05778253 ·Status: RECRUITING
-
Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC
NCT05873439 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Metabolomics Predict Therapy Response
NCT03736993 ·Status: COMPLETED ·Phase: NA
-
Radiomics and Radiogenomics of Non-small Cell Lung Cancer
NCT06331975 ·Status: COMPLETED ·Phase: NA
-
Gene Molecular Alterations as Disease Prognostic Markers in Patients With Non-small Cell Lung Cancer (NSCLC)
NCT06876402 ·Status: ACTIVE_NOT_RECRUITING
-
Decoding the Association of Imaging and Tumor Microenvironment in Lung Cancer Using Radiogenomic Approach（Radiogenomics-Lung）
NCT06500312 ·Status: RECRUITING
-
Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease
NCT01450553 ·Status: UNKNOWN
-
Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer
NCT07288632 ·Status: RECRUITING
-
Molecular and Genetic Analysis of Lung Cancer
NCT03029325 ·Status: RECRUITING
-
Broncho-Vascular Lung Sparing Reconstructions and Pneumonectomies in Patients With Non Small Cell Lung Cancer
NCT06835231 ·Status: ACTIVE_NOT_RECRUITING
-
An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy
NCT00721981 ·Status: TERMINATED
-
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China
NCT03059641 ·Status: COMPLETED
-
SHOX2_PTGER4 DNA Methlyation in Lung Cancer
NCT04321499 ·Status: COMPLETED
-
Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma
NCT05830812 ·Status: RECRUITING
-
Epidemiologic Multicenter Prospective Study in Advanced NSCLC (Non Small Cell Lung Cancer) Patients With PDL1 (Protein Death Ligand 1) Expression.
NCT02785562 ·Status: COMPLETED ·Phase: NA